Tumor necrosis factor-related genes and colon and rectal cancer

International Journal of Molecular Epidemiology and Genetics

Volumn 2, Issue 4, 2011, Pages 328-338

  Slattery, Martha L ^a   Lundgreen, Abbie ^a   Bondurant, Kristina L ^b   Wolff, Roger K ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Colon cancer; MAPK14; MAPK8; NFAM1; NFAT5; Rectal cancer; TNF; TNFRSF1A; TRAF2

Indexed keywords

ACETYLSALICYLIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 7; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CIGARETTE SMOKING; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RECTUM CANCER;

EID: 83655181223     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gao Z, Zuberi A, Quon MJ, Dong Z, Ye J. Aspirin Inhibits Serine Phosphorylation of Insulin Receptor Substrate 1 in Tumor Necrosis Factortreated Cells through Targeting Multiple Serine Kinases. J Biol Chem 2003; 278: 24944-24950.
2. Xu H, Hotamisligil GS. Signaling pathways utilized by tumor necrosis factor receptor 1 in adipocytes to suppress differentiation. FEBS Lett 2001; 506: 97-102.
3. Hotamisligil GS. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245: 621-625.
4. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996; 271: 665-668.
5. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 1994; 134: 264-270.
6. Kuhnel F, Zender L, Paul Y, Tietze MK, Trautwein C, Manns M, Kubicka S. NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem 2000; 275: 6421-6427.
7. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007; 121: 2373-2380.
8. Natoli G, Costanzo A, Guido F, Moretti F, Bernardo A, Burgio VL, Agresti C, Levrero M. Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J Biol Chem 1998; 273: 31262-31272.
9. McClung JM, Judge AR, Powers SK, Yan Z. p38 MAPK links oxidative stress to autophagyrelated gene expression in cachectic muscle wasting. Am J Physiol Cell Physiol 2010; 298: C542-549.
10. Wu GS. Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer. Cancer Metastasis Rev 2007; 26: 579-585.
11. Hong S, Lim S, Li AG, Lee C, Lee YS, Lee EK, Park SH, Wang XJ, Kim SJ. Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol 2007; 8: 504-513.
12. Viemann D, Goebeler M, Schmid S, Klimmek K, Sorg C, Ludwig S, Roth J. Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinasedependent gene expression in TNF-alphastimulated primary human endothelial cells. Blood 2004; 103: 3365-3373.
13. Ohtsuka M, Arase H, Takeuchi A, Yamasaki S, Shiina R, Suenaga T, Sakurai D, Yokosuka T, Arase N, Iwashima M, Mitamura T, Moriya H, Saito T. NFAM1, an immunoreceptor tyrosinebased activation motif-bearing molecule that regulates B cell development and signaling. Proc Natl Acad Sci USA 2004; 101: 8126-8131.
14. Yang J, Hu G, Wang SW, Li Y, Martin R, Li K, Yao Z. Calcineurin/nuclear factors of activated T cells (NFAT)-activating and immunoreceptor tyrosine-based activation motif (ITAM)- containing protein (CNAIP), a novel ITAMcontaining protein that activates the calcineurin/ NFAT-signaling pathway. J Biol Chem 2003; 278: 16797-16801.
15. Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, Berry TD. Energy balance and colon cancer--beyond physical activity. Cancer Res 1997; 57: 75-80.
16. Slattery ML, Edwards S, Curtin K, Ma K, Edwards R, Holubkov R, Schaffer D. Physical activity and colorectal cancer. Am J Epidemiol 2003; 158: 214-224.
17. Edwards S, Slattery ML, Mori M, Berry TD, Caan BJ, Palmer P, Potter JD. Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 1994; 140: 1020-1028.
18. Conneely KN, Boehnke M. So Many Correlated Tests, So Little Time! Rapid Adjustment of P Values for Multiple Correlated Tests. Am J Hum Genet 2007; 81: 1158-1168.
19. Carpentier I, Declercq W, Malinin NL, Wallach D, Fiers W, Beyaert R. TRAF2 plays a dual role in NF-kappaB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and IkappaB kinase pathways. FEBS Lett 1998; 425: 195-198.
20. Machado FS, Esper L, Dias A, Madan R, Gu Y, Hildeman D, Serhan CN, Karp CL, Aliberti J. Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6. J Exp Med 2008; 205: 1077-1086.
21. Otsuka M, Kang YJ, Ren J, Jiang H, Wang Y, Omata M, Han J. Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. Gastroenterology 2010; 138: 1255-1265, 1265 e1251-1259.
22. Jin S, Ray RM, Johnson LR. TNF-alpha/ cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species. Am J Physiol Gastrointest Liver Physiol 2008; 294: G928-937.
23. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 1995; 270: 3780-23784.
24. Belgardt BF, Mauer J, Bruning JC. Novel roles for JNK1 in metabolism. Aging (Albany NY) 2010; 2: 621-626.